Micropoint BioScience Commitment
to Support Continued Health and Safety
Micropoint is committed to responding to the COVID-19 pandemic. We have taken active measures to ensure the health and safety of our colleagues and to maintain the supply of our COVID-19 diagnostic tools in regions where they are sold.
Micropoint has developed two rapid, 15-minute point-of-care test for COVID-19.
The ezLabs COVID-19 Antigen Test, a rapid in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 virus antigen present in human nasopharynx.
The mLabs SARS-CoV-2 IgG and IgM assay, a fluorescent microparticle immunoassay intended for the qualitative detection of the total IgC and IgM antibodies to SARS-CoV-2 in human whole blood, and plasma.